User profiles for Lana Yin Hui Lai
 | Lana Yin Hui LaiUniversity of Manchester Verified email at bu.edu Cited by 726 |
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study
Objective To investigate the use of repurposed and adjuvant drugs in patients admitted to
hospital with covid-19 across three continents. Design Multinational network cohort study. …
hospital with covid-19 across three continents. Design Multinational network cohort study. …
[HTML][HTML] Thirty-day outcomes of children and adolescents with COVID-19: an international experience
OBJECTIVES To characterize the demographics, comorbidities, symptoms, in-hospital
treatments, and health outcomes among children and adolescents diagnosed or hospitalized with …
treatments, and health outcomes among children and adolescents diagnosed or hospitalized with …
[HTML][HTML] Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a …
Background Adverse events of special interest (AESIs) were pre-specified to be monitored
for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines, but with …
for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines, but with …
[HTML][HTML] Baseline characteristics, management, and outcomes of 55,270 children and adolescents diagnosed with COVID-19 and 1,952,693 with influenza in France …
Objectives To characterize the demographics, comorbidities, symptoms, in-hospital treatments,
and health outcomes among children/adolescents diagnosed or hospitalized with COVID-…
and health outcomes among children/adolescents diagnosed or hospitalized with COVID-…
[HTML][HTML] Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom
Background A detailed characterization of patients with COVID-19 living with obesity has
not yet been undertaken. We aimed to describe and compare the demographics, medical …
not yet been undertaken. We aimed to describe and compare the demographics, medical …
CYP2C19 genotypes and their impact on clopidogrel responsiveness in percutaneous coronary intervention
Background Cytochrome P450 2C19 (CYP2C19) loss-of-function polymorphisms are more
common in Asian populations and have been associated with diminished antiplatelet …
common in Asian populations and have been associated with diminished antiplatelet …
Association between glucocorticoid therapy and incidence of diabetes mellitus in polymyalgia rheumatica and giant cell arteritis: a systematic review and meta …
Background Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are almost always
treated with glucocorticoids (GCs), but long-term GC use is associated with diabetes mellitus …
treated with glucocorticoids (GCs), but long-term GC use is associated with diabetes mellitus …
Clinical characteristics, symptoms, management and health outcomes in 8,598 pregnant women diagnosed with COVID-19 compared to 27,510 with seasonal …
OBJECTIVES To describe comorbidities, symptoms at presentation, medication use, and 30-day
outcomes after a diagnosis of COVID-19 in pregnant women, in comparison to pregnant …
outcomes after a diagnosis of COVID-19 in pregnant women, in comparison to pregnant …
[HTML][HTML] Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 842,928 patients hospitalized with COVID-19 in the United States
… Shah, 29 Jitendra Jonnagaddala, 30 Lana Yin Hui Lai, 31 Francesc Xavier Avilés-Jurado,
32, 33 George Hripcsak, 5 Marc A. Suchard, 34 Otavio T. Ranzani, 35, 36 Patrick Ryan, 3 …
32, 33 George Hripcsak, 5 Marc A. Suchard, 34 Otavio T. Ranzani, 35, 36 Patrick Ryan, 3 …
Characteristics and outcomes of 627 044 COVID-19 patients with and without obesity in the United States, Spain, and the United Kingdom
Background COVID-19 may differentially impact people with obesity. We aimed to describe
and compare the demographics, comorbidities, and outcomes of obese patients with COVID-…
and compare the demographics, comorbidities, and outcomes of obese patients with COVID-…
